Table 2.
Correlation between NEDD9 expression and clinicopathological features of TNBC
| Parameters | NEDD9 expression
|
t/χ2 value | P-value | |
|---|---|---|---|---|
| Low | High | |||
| Age (years) | 0.537 | 0.464 | ||
| ≤50 | 10 | 31 | ||
| >50 | 12 | 53 | ||
| Menopausal status | 1.515 | 0.218 | ||
| Premenopausal | 15 | 45 | ||
| Postmenopausal | 7 | 39 | ||
| Histological type | 0.095 | 0.758 | ||
| Ductal | 20 | 78 | ||
| Lobular | 2 | 6 | ||
| Size | 2.584 | 0.108 | ||
| ≤2 cm | 12 | 30 | ||
| >2 cm | 10 | 54 | ||
| Pathological grade | 2.625 | 0.105 | ||
| I and II | 15 | 41 | ||
| III | 7 | 43 | ||
| LN metastasis | 5.384 | 0.020 | ||
| 0 | 15 | 34 | ||
| ≥1 | 7 | 43 | ||
| TNM stage | 10.016 | 0.014 | ||
| I | 12 | 16 | ||
| II | 6 | 37 | ||
| III | 4 | 25 | ||
| IV | 0 | 6 | ||
Abbreviations: LN, lymph node; NEDD9, neural precursor cell expressed, developmentally downregulated 9; TNBC, triple-negative breast cancer; TNM, tumor-node-metastasis.